Mirum Pharmaceuticals
MIRM
58 hedge funds and large institutions have $366M invested in Mirum Pharmaceuticals in 2020 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 16 increasing their positions, 9 reducing their positions, and 5 closing their positions.
300% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 5
78% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 9
41% more capital invested
Capital invested by funds: $260M → $366M (+$106M)
35% more funds holding
Funds holding: 43 → 58 (+15)
0.8% more ownership
Funds ownership: 73.28% → 74.08% (+0.8%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$5M |
| 2 |
BlackRock
New York
|
+$2.82M |
| 3 |
SI
Sofinnova Investments
Menlo Park,
California
|
+$2.06M |
| 4 |
Morgan Stanley
New York
|
+$1.65M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$1.63M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PC
Polar Capital
London,
United Kingdom
|
-$10.8M |
| 2 |
Millennium Management
New York
|
-$1.41M |
| 3 |
EGI
EAM Global Investors
Solana Beach,
California
|
-$969K |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$958K |
| 5 |
EI
EAM Investors
Solana Beach,
California
|
-$754K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SO
51
STRS Ohio
Columbus,
Ohio
| $13K | – | – | – |
|
|
DWA
52
Dorsey Wright & Associates
Pasadena,
California
| $11K | +$9.19K | +550 | New |
|
|
LC
53
Lindbrook Capital
Calabasas,
California
| $10K | +$8.36K | +500 | New |
|
54
Bank of Montreal
Toronto,
Ontario, Canada
| $8K | +$6.68K | +400 | New |
|
|
PA
55
Parallel Advisors
San Francisco,
California
| $7K | – | – | – |
|
|
AIP
56
Ameritas Investment Partners
Lincoln,
Nebraska
| $4K | – | – | – |
|
|
CSS
57
Cubist Systematic Strategies
Stamford,
Connecticut
| $2K | +$1.67K | +100 | New |
|
|
PC
58
Polar Capital
London,
United Kingdom
| – | -$10.8M | -769,425 | Closed |
|
|
EGI
59
EAM Global Investors
Solana Beach,
California
| – | -$969K | -69,237 | Closed |
|
|
EI
60
EAM Investors
Solana Beach,
California
| – | -$754K | -53,832 | Closed |
|
|
SCM
61
Sio Capital Management
New York
| – | -$150K | -10,701 | Closed |
|
62
Victory Capital Management
San Antonio,
Texas
| – | -$56K | -3,958 | Closed |
|
63
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$4.25K | -254 | -95% |
|
MIRM Hedge Fund Activity: Q2 2020 in Review
58 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Mirum Pharmaceuticals (MIRM) for Q2 2020, worth a combined $366M — up 41% from $260M a quarter earlier.
Buyers outnumbered sellers: 20 funds opened new MIRM positions and 5 closed out — a net gain of 15 holders — while 16 added to existing stakes and 9 trimmed.
The largest buyer was Vanguard Group, adding an estimated $5M. The largest seller was Polar Capital, exiting entirely with an estimated $10.8M sold.
- 58 institutional investors held Mirum Pharmaceuticals (MIRM) as of Q2 2020, up from 43 in Q1 2020.
- Funds reported $366M of Mirum Pharmaceuticals stock for Q2 2020, up 41% quarter-over-quarter.
- 20 funds opened new Mirum Pharmaceuticals positions in Q2 2020 and 5 closed out, a net change of +15 holders.
- The largest Mirum Pharmaceuticals buyer in Q2 2020 was Vanguard Group, an estimated $5M added.
- The largest Mirum Pharmaceuticals seller in Q2 2020 was Polar Capital, an estimated $10.8M sold.
Based on aggregated 13F filings for Q2 2020.